Key result
Hypertension is linked to ~22% lower podocyte density, with no added deficit from T2DM.
Why the study?
Does coexisting type 2 diabetes exacerbate podocyte depletion and glomerular alterations in patients with hypertension?
Observational (n=99)
Does coexisting type 2 diabetes exacerbate podocyte depletion and glomerular alterations in patients with hypertension?
Answers are grounded in this paper and cite their sources.
Coexisting type 2 diabetes does not appear to contribute additional glomerular and podocyte alterations beyond those observed in hypertension alone.
BACKGROUND: Arterial hypertension (HTN) and type 2 diabetes (T2DM) are contributors to chronic kidney disease leading to glomerulomegaly and podocyte loss. Enlarged glomeruli and podocyte depletion are associated with kidney disease progression. This retrospective study aimed to investigate morphometric changes in patients with HTN and the contribution of coexisting T2DM in HTN. METHODS: Glomerular and podocyte structure was estimated stereologically in unaffected areas of tumor nephrectomies in 99 patients. Morphometric features between subjects with HTN (n=47), HTN+T2DM (n=32), and controls without HTN and T2DM (n=20) were compared by ANOVA. Linear regression models evaluated the effect of morphometric parameters on renal compensation after nephrectomy (change of estimated glomerular filtration rate from pre-nephrectomy to 12 months post-nephrectomy). RESULTS: In total, 36% of the HTN and 50% of the patients with T2DM exhibited dipstick-positive proteinuria. Glomerular volume in HTN+T2DM was similar compared with controls (2.7±0.8 versus 2.3±0.8×10 6 µm³; P =0.16) and to HTN only (2.7±0.9×10 6 µm³; P =0.95). Podocyte density was reduced in HTN+T2DM versus controls (217±66 versus 279±75 per 10 6 µm³; P =0.02) and not different to HTN only (233±87 per 10 6 µm³; P =0.67). Podocyte nuclear volume was larger in HTN+T2DM versus controls (230±28 versus 201±32 µm³; P =0.004) and similar to HTN (221±33 µm³; P =0.39). Larger glomerular volume ( P =0.009), reduced podocyte density ( P =0.003), and nuclear hypertrophy ( P =0.01) were associated with impaired compensation. CONCLUSION: The patterns of podocyte depletion and nuclear hypertrophy were independently observed in both HTN and HTN+T2DM versus controls. Coexisting T2DM exhibited no additional contribution to glomerular and podocyte alterations.
No takes yet. Share an insight, caveat, or question.
Paschen et al. (2025) conducted an observational in Hypertension and Type 2 Diabetes (n=99). Hypertension with coexisting Type 2 Diabetes (HTN+T2DM) vs. Controls without HTN and T2DM was evaluated on Podocyte density (per 10^6 µm³) (p=0.02). Hypertension with or without type 2 diabetes was associated with reduced podocyte density compared to controls, with no additional contribution from coexisting T2DM.
Synapse has enriched 10 related papers. Consider them for comparative context: